Skip to content

Menu

US Markets
US Economy
Business
Finance
Technology
Subscribe Now For Free

US Markets
US Economy
Business
Finance
Technology
Subscribe Now For Free

US Markets
US Economy
Business
Finance
Technology
Subscribe Now For Free

NASDAQ: SRPT

Sarepta

H.C. Wainwright Upgrades Sarepta to Neutral on Valuation Ahead of Q1 Results

Davit Kirakosyan / 2 April 2025

H.C. Wainwright upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Sell to Neutral with a new 12-month price target of $75. The […]

H.C. Wainwright Upgrades Sarepta to Neutral on Valuation Ahead of Q1 Results Read More »

Sarepta Therapeutics

Sarepta Therapeutics (NASDAQ: SRPT) Stock Sinks Over Patient Death News

Mary Lee / 19 March 2025

Shares of Sarepta Therapeutics (NASDAQ: SRPT) plunged more than 27% in regular trading Tuesday following the company’s online statement about

Sarepta Therapeutics (NASDAQ: SRPT) Stock Sinks Over Patient Death News Read More »

Company

Become A Contributor

Categories

Legal

Editorial Policy

Modern Slavery Statement

Anti Bribery And Corruption Policy

Top Tech Stocks 2025

Top Bank Stocks 2025

Worst Stocks 2025

We Are Licensed Partners Of Reuters

Copyright © 2025 abbonews.com